Curis, Inc. News
Curis Shares Stabilize After Rout as Analysts Reiterate Price Targets
Curis trades higher as analysts reiterate their outlooks after the stock loses more than a third of its market value on disappointing trial results.
Curis Drops; Lower Dose of Leukemia Drug to Reach Phase 2 Study
Curis said it would take a lower dose of its leukemia treatment into Phase 2 studies after higher doses showed toxicities.
Curis Skyrockets on Positive Phase 1 Test for Lymphoma Treatment
Results showed the treatment 'provides potent and durable anti-cancer activity' for certain lymphoma patients, Curis said.
Biotech Premarket Movers: Spectrum, BioCryst, Curis
Spectrum Pharmaceuticals, BioCryst Pharmaceuticals and Curis were among the biotech stock movers in premarket trading on Thursday.
These 7 stocks under $10 are making big moves higher. Here's how to trade them now.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.